Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability and Effectiveness of Extended Dosing of Liposomal Amphotericin B (L-AmB) for Primary Prophylaxis of Invasive Fungal Disease in High-risk Pediatric Patients: a Retrospective Multicenter Study

NCT06640296 is registered in ClinicalTrials.gov with Istituto Giannina Gaslini as lead sponsor.

NCT NCT06640296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06640296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability and Effectiveness of Extended Dosing of Liposomal Amphotericin B (L-AmB) for Primary Prophylaxis of Invasive Fungal Disease in High-risk Pediatric Patients: a Retrospective Multicenter Study
Lead sponsor
Istituto Giannina Gaslini
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 12, 2023
Completion date
May 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive fungal disease, invasive fungal infections, prophylaxis